DiEthylStilbestrol Resources: Cancer, Breast Cancer, CCAC, Vaginal Cancer, Screening

Cancer

NCBI PubMed DiEthylStilbestrol Resources: Cancer, Breast Cancer, CCAC, Vaginal Cancer, Screening.

• Aneuploidy Induction and Cell Transformation by Diethylstilbestrol: A Possible Chromosomal Mechanism in Carcinogenesis – 1983
• Animal models of prenatal exposure to diethylstilboestrol – 1989
• Cancer risk in DES daughters – 2010
• Cancer risk in diethylstilbestrol-exposed offspring – 1976
• Cancer Risk in Men exposed in Utero to DiEthylStilbestrol – 2001
• Cancer Risk in Women exposed to DiEthylStilbestrol in Utero – 1998
• Cancer Risk in Women Exposed to Diethylstilbestrol in Utero – 2015
• Cancer Risk in Women prenatally exposed to DiEthylStilbestrol – 2007
• Childhood cancer: overview of incidence trends and environmental carcinogens – 1995
• Critical windows of exposure for children’s health: cancer in human epidemiological studies and neoplasms in experimental animal models – 2000
• Diethylstilbestrol Genetics, Teratogenesis, and Tumor Spectrum in Humans – 1985
• Diethylstilboestrol: Pharmacology, Toxicology and Carcinogenicity in Experimental Animals – 1992
• Endocrine Disruptors in Female Reproductive Tract Development and Carcinogenesis – 2009
• Epidemiological studies of the effects of diethylstilboestrol – 1989
• Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol – 1998
• Introduction and overview. Perinatal carcinogenesis: growing a node for epidemiology, risk management, and animal studies – 2004
• Lessons learned from Perinatal Exposure to DiEthylStilbestrol – 2004
• Multi-generational Carcinogenesis from DiEthylStilbestrol investigated by Blastocyst Transfers in Mice – 1995
• Occurrence of tumours in the descendants of CBA male mice prenatally treated with diethylstilbestrol – 1992
• Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation – 2008
• Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol – 2000
• Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure – 2005

– Breast Cancer

• 2015 Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo.
• 2014 Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters.
• 2013 Does cancer start in the womb? Altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors.
• 2013 Exposure to Synthetic Estrogens at different Times during the Life and their Side Effects on Breast Cancer Risk.
• 2013 Prenatal DES Exposure in Relation to Breast Size
• 2010 In Utero Exposure to Diethylstilbestrol (DES) or Bisphenol-A (BPA) Increases EZH2 Expression in the Mammary Gland: An Epigenetic Mechanism Linking Endocrine Disruptors to Breast Cancer
• 2006 Birth weight and breast cancer risk.
• 2006 Prenatal DiEthylStilbestrol Exposure and Risk of Breast Cancer.
• 2005 Breast cancer incidence in women prenatally exposed to maternal cigarette smoke.
• 2005 Management of breast cancer in patients prenatally exposed to diethylstilbestrol: are we prepared?.
• 2002 Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States).
• 2001 Long-Term Cancer Risk in Women given DiEthylStilbestrol (DES) during Pregnancy.
• 1993 Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up.
• 1978 A Twenty-Five-Year Follow-Up Study of Women exposed to DiEthylStilbestrol during Pregnancy.

– Clear Cell AdenoCarcinoma and Vaginal Cancer

• A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol – 1985
• Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix – 1977
• Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring – 1984
• Adenocarcinoma of the Vagina — Association of Maternal Stilbestrol Therapy with Tumor Appearance in Young Women – 1971
• Clear Cell AdenoCarcinoma and the current Status of DES-exposed Females – 1981
• Clear Cell Adenocarcinoma of the Ovary Associated With In Utero Diethylstilbestrol Exposure: Case Report and Clinical Overview – 2009.
• Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks – 1997.
• Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol – 1988
• Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine diethylstilbestrol exposure – 1990
• Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era – 2008
• Colposcopic evaluation of DES-exposed progeny at two large medical centers: the squamous neoplasia problem – 1978
• Development of cervical and vaginal squamous cell neoplasia as a late consequence of in utero exposure to diethylstilbestrol – 2008
• Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain – 2007
• Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project – 1981
• Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix – 1979
• Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero – 1977
• Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix – 2018.
• Genital clear cell adenocarcinoma – 1983
• Incidence of squamous neoplasia of the cervix and vagina in DES-exposed daughters – 2000
• Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States) – 2001
• Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project – 1984
• Ovarian Carcinoma in an Adolescent with TransGenerational Exposure to DiEthylStilbestrol – 2003
• Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract – 2016
• Primary Vaginal Mucinous Adenocarcinoma of Intestinal Type, Associated With Intestinal Metaplasia of Skene Ducts in a Diethylstilbestrol-Exposed Woman – 2015
• Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update – 1987
• Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters – 2016
• Roles of p63 in the DiEthylStilbestrol-induced CervicoVaginal Adenosis – 2004
• Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol – 1978
• Squamous cell carcinoma in situ of the vagina and cervix after intrauterine DES exposure – 1978
• The Development of Cervical and Vaginal Adenosis as a Result of Diethylstilbestrol Exposure In Utero – 2012
• Vaginal Adenosis and AdenoCarcinoma in Mice exposed PreNatally or NeoNatally to DiEthylStilbestrol – 1982
• Vaginal adenosis and diethylstilboestrol – 1984
• Vaginal and Cervical Abnormalities, including CCA, related to PreNatal Exposure to Stilbestrol – 1974
• Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones – 1977
• Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic – 2009.
• Vaginal and cervical squamous cell dysplasia in women exposed to diethylstilbestrol in utero – 1978
• Very late recurrence of Diethylstilbestrol – related clear cell carcinoma of the cervix: case report – 2015

– Screening

• Breast Cancer Screening in Women exposed in Utero to DiEthylStilbestrol – 2009
• Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic – 1988
• Cervical intraepithelial neoplasia associated with exposure to diethylstilbestrol in utero: a clinical and pathologic study – 1981
• Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol – 2008
• Colposcopic evaluation of DES-exposed progeny at two large medical centers: the squamous neoplasia problem – 1978
• Colposcopic findings and intraepithelial neoplasia in diethylstilbestrol-exposed offspring. The Dutch experience – 1990
• Development of DES-associated clear-cell carcinoma: the importance of regular screening – 1979
• Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals – 2003
• Factors associated with a lack of pap smear utilisation in women exposed in utero to diethylstilbestrol – 2015
• Identification and management of DES-exposed women – 1988
• Magnetic resonance imaging of Müllerian duct anomalies in children – 2016
• Mammography Screening Behaviors of Women exposed prenatally to DiEthylStilbestrol – 2012
• Six years’ experience with screening of a diethylstilbestrol-exposed population – 1979
• The management of DES-exposed women: one physician’s approach – 1976
• Value of screening procedures for the detection of vaginal adenosis –  1976

More DES DiEthylStilbestrol Resources

• DES studies on cancers and screening.
• DES studies on epigenetics and transgenerational effects.
• DES studies on fertility and pregnancy.
• DES studies on gender identity and psychological health.
• DES studies on in-utero exposure to DES and side-effects.
• DES studies on the genital tract.
• Papers on DES lawsuits.
• DES videos and posts tagged DES, the DES-exposed, DES victims.